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Human immunodeficiency virus type 1 (HIV-1) non-B clade viral infections of the brain have not been studied to date.
Among nine AIDS patients from Nairobi, Kenya, infected with HIV-1 A (N 5 5) or D (N 5 4) clade strains, brain-derived HIV-1
env sequences displayed greater evolutionary distance than B clade brain-derived viruses (P , 0.001). Similarly, molecular
diversity between matched brain and spleen env clones was clade-dependent and concentrated in the hypervariable V4
region (P , 0.001), with phylogenetic clustering of sequences derived from the same organ. Brain-derived A and D clade
sequences displayed significantly lower ratios of nonsynonymous/synonymous substitution rates (dN/dS) compared to
matched spleen-derived clones and brain-derived B clade viruses. Interclade recombination events were infrequently
observed among the present env sequences. A chimeric virus containing the C2V3 region from an A clade brain-derived
sequence preferentially used CD4 and CCR5 for infection. These findings demonstrate that differences in molecular diversity
in brain-derived sequences were dependent on the individual clade and domain within the env gene, but both B and non-B
clade brain-derived viruses exhibit a preference for CCR5 as a coreceptor. © 2001 Academic PressINTRODUCTION
Like all lentiviruses, human immunodeficiency virus
type 1 (HIV-1) is neurotropic, although the mechanisms
by which the virus enters and infects the brain remain
uncertain (reviewed in Johnson, 1998). All previous stud-
ies of HIV-1 derived from the brain have examined B
clade (subtype) viruses isolated from North American
and European patients (Hughes et al., 1997; Li et al.,
1991; Pang et al., 1991; Reddy et al., 1996). B clade
brain-derived HIV-1 is macrophage-tropic, which is
largely dependent on viral utilization of the CCR5 che-
mokine receptor although other chemokine receptors
have been implicated in HIV-1 neuropathogenesis
(Alkhatib et al., 1996; Chan et al., 1999; Choe et al., 1996;
Deng et al., 1996; Doranz et al., 1996; Dragic et al., 1996;
Wang et al., 1999). Previous studies showed sequence
differences between matched brain- and different organ-
derived HIV-1 env genes (Epstein et al., 1991; Hughes et
al., 1997) with similar findings among other viral genes,
including the tat (Mayne et al., 1998), gag (Morris et al.,
1999), and pol (Wong et al., 1997) genes. Evolutionary
1 To whom correspondence and reprint requests should be ad-
ressed at the Neuroscience Research Group, Department of Clinical
euroscience, University of Calgary, 3330 Hospital Drive NW, Calgary,
lberta, T2N 4N1, Canada. Fax: (403) 283-8731. E-mail:
ower@ucalgary.ca.
19diversity among HIV-1 sequences from different organs
within the same individual is dependent on the gene
being examined; env sequences tend to show the great-
est diversity because of the increased susceptibility of
env to differing selection influences (Morris et al., 1999).
Furthermore, it has been postulated that viral recombi-
nation may play a role in the development of sequence
diversity (Morris et al., 1999; Neilson et al., 1999; Robert-
son et al., 1995a). Studies examining blood-derived HIV-1
sequences have shown that a more aggressive disease
course and advanced disease status are associated with
increased molecular diversity (Markham et al., 1998;
Nowak et al., 1991; Wolinsky et al., 1996). The disease
course among patients in sub-Saharan Africa and South-
east Asia may be more rapid than in North America or
Western Europe, with shorter survival times and shorter
intervals between seroconversion and the development
of AIDS, depending on the HIV-1 clade (Kanki et al., 1999;
McCutchan et al., 1996a; Poss and Overbaugh, 1999).
Similarly, HIV-1 env sequences from patients with HIV-1
associated dementia display higher levels of viral mo-
lecular diversity than nondemented AIDS patients
(Kuiken et al., 1995; Power et al., 1994). In the present
study, the molecular features and coreceptor usage of
brain-derived and matched spleen-derived env se-
quences from patients in Nairobi, Kenya, were examined,
where several HIV-1 clades have been previously re-
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
s
c
m
c
q
i
p
7
l
d
g
f
p
t
a
v
c
r
A
v
s
c
v
c
l
m
t
b
a
(
i
.
20 ZHANG ET AL.ported (Belda et al., 1997; Neilson et al., 1999; Robertson
et al., 1995a).
RESULTS
A total of 73 brain- and spleen-derived gp120 encoding
sequences were obtained from nine patients (6–15
clones for each patient). HIV-1 clade categorization with
the NCBI subtyping HIV-1 program revealed that four
patients were infected with D clade viruses and five with
A clade viruses (Table 1). In all nine patients, clones from
brain and spleen for each patient belonged to the same
clade. A rooted neighbor-joining phylogenetic tree was
constructed using these 73 sequences of deduced
amino acid (aa) from the brain- and spleen-derived
clones (Fig. 1). These sequences were compared to
prototypic B clade viruses, based on the V1-V5 region of
gp120. Sequences from these three clades (A, D, and B)
were grouped separately into three lineages with boot-
strap resampling supporting the distinction of these
clades (bootstrap value $ 90%) (Fig. 1), which further
confirmed the above subtyping result. The sequences
from brain or spleen clustered together phylogenetically
within individual patients with high bootstrap values
(bootstrap support of $99%, except patient 75 with 82%),
whether based on amino acid (Fig. 1) or nucleotide (data
not shown) sequences. Moreover, this host-dependent
clustering of sequences was also observed when dis-
crete gp120 gene regions (V1, V2, C2, V3, C3, V4, C4, and
V5) were compared (data not shown).
Although limited diversity among brain-derived B clade
HIV-1 env sequences has been reported (Li et al., 1991;
Pang et al., 1991; Reddy et al., 1996), the extent of diver-
ity within the gp120 fragment in the present non-B-
lade-infected patients was examined by comparing
ultiple clones from brain and spleen (three to seven
lones from each tissue). Brain- and spleen-derived se-
uences consistently clustered within individuals, tend-
T
Patient C
Subject number Age (years) Sex HIV-1 clad
76 28 M A
118 52 F A
58 35 M A
104 37 M A
99 30 M A
100 40 F D
75 29 M D
108 31 M D
102 42 F D
a As defined both in Fig. 1 and in the NCBI subtyping HIV-1 program
b Mycobacterium tuberculosis.ng toward the tissue of origin (Fig. 1). Within individual
atients, comparison of similarity among brain-derivedclones ranged from 76.4 to 100% (mean 6 SEM, 93.088 6
.156), while in spleen-derived samples sequence simi-
arity ranged from 72.1 to 100% (mean 6 SEM, 95.215 6
3.431) when predicted amino acid differences were com-
pared. However, the mean similarity was 86.426 6 6.042
(range 68.8 to 99.8%) when comparing matched brain to
spleen sequences within individuals, which differed from
the inter-brain or -spleen comparisons (P , 0.0001).
These analyses also revealed limited diversity within
multiple clones from the same tissue and that brain and
spleen sequences were evolutionarily divergent, consis-
tent with the previous reports (Epstein et al., 1991; Gart-
ner et al., 1997; Korber et al., 1994; Li et al., 1991; Monken
et al., 1995, 1991; Power et al., 1994). To determine which
omain(s) within gp120 displayed the greatest diver-
ence between brain- and spleen-derived sequences
rom the same patient, sequence diversity was com-
ared for all nine patients (Fig. 2A). Within the V4 region,
here was significantly greater diversity between brain
nd spleen among D clade viruses than among A clade
iruses. Within the V3 region, the diversity within the D
lade viruses was greater than within the A clade vi-
uses, whereas within the V1 region diversity within the
clade viruses was greater than within the D clade
iruses, although not statistically significant. These re-
ults suggested that selective pressures acting on dis-
rete domains within the virus differed depending on the
iral clade.
To compare evolutionary differences among A and D
lade viruses derived from both brain and spleen, calcu-
ations of mean pairwise total distance (d) and synony-
ous (ds) and nonsynonymous (dN) substitution rates for
he entire gp120 sequence were made (Nei and Gojo-
ori, 1986) using the MEGA package (Kumar et al., 1993)
nd compared to prototype B clade brain-derived viruses
Table 2). B clade brain-derived viruses displayed signif-
cantly lower substitution rates for d, dS, and dN than the
Features
General autopsy findings Clinical features
Disseminated TBb Sepsis
Bacterial pneumonia Cough, fever
Disseminated TB Hemoptysis, chest pain
Disseminated TB Cough, fever, confusion
Disseminated TB Confusion, nuchal rigidity
Cryptococcal meningitis Fever, vomiting, nuchal rigidity
Disseminated TB Confusion, headache, fever
Cryptococcal meningitis Coma, nuchal rigidity, fever
Pneumonia Confusion, feverABLE 1
linical
eaA and D clade brain-derived viruses. In contrast, the
mean ratio of nonsynonymous to synonymous mutations
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21HIV-1 CLADE A AND D NEUROTROPISM(dN/dS) for both A and D brain-derived sequences was
FIG. 1. Phylogenetic tree of multiple HIV-1 env (gp120) sequences
ompared to the prototypic B clade viruses. The tree was constructe
djacent sides) of gp120 (approximately 400 aa) by neighbor-joining a
Kumar et al., 1993). The number at each node indicates the bootstrap va
s indicated below. Con-A, -D, and -B indicate consensus sequences fo
updated November 1999). The prototypic clade B viruses are GC, DS
lones, ADA and BAL from reported M-tropic viruses, and NL4-3, HXB
rain- and spleen-derived clones, together with patient number (#) in th
oot the tree.less than those of the B clade viruses and matched
spleen sequences. To extend this analysis of molecularvariation within the different clades, the diversity within
aired brain- and spleen-derived clones of nine patients (73 clones)
d on the V1-V5 region (including extra 20–40 amino acids from both
with pairwise gap stripping and p-distance using the MEGA program
s determined from 100 bootstrap resamplings. The scale for p-distance
s A, D, and B obtained from the Los Alamos HIV Sequence Database
d RC (Gartner et al., 1997), JRFL, SF162, and YU-2 from brain-derived
, MN, SF2, and SF33 from reported T-tropic viruses. B and S indicate
ent A and D clade sequences. CPZ-GAB was used as the outgroup tofrom p
d base
nalysis
lues a
r clade
, KJ, an
2, HANindividual domains of gp120 was examined among A and
D clade brain- and spleen-derived viruses, compared to
sterisk
22 ZHANG ET AL.prototype B clade brain-derived viruses, in addition to
previously reported B clade brain-derived sequences (for
FIG. 2. Divergence and nonsynonymous substitution rates in different
brain- and spleen-derived gp120 sequences in multiple regions that was
aligned using the Clustal method with the residue identity weight table
the line using HXB2 gp120 amino acid numbering. The divergence (%)
was calculated by the DNAStar program. The individual bars represen
for each patient. An asterisk indicates a difference between the groups
substitution rates (6SEM) (dN) in different gp120 domains among bra
brain-derived virus group (B-Brain-1) includes GC, DS, KJ, and RC, JRF
B clade brain sequence group (B-Brain-2) (V1-V3 only) includes sequen
calculated as previously reported (Nei and Gojobori, 1986). The distan
in the other groups to determine if they were significantly different. An a
and **P , 0.001).V1-V3 domains only) that were obtained by methods
similar to those of the present study (Power et al., 1994,1998) (Fig. 2B). The nonsynonymous substitution dis-
tance was markedly increased for all viruses in the V1
domains from clade A and D viruses. (A) Divergence between matched
dent on viral clade in the V1, V3, and V4 domains. The sequences were
AStar and then divided into segments as indicated in the figure below
oportion of different amino acids between two compared sequences)
ean diversity between matched brain- and spleen-derived sequences
D clade sequences (Student’s t test, P , 0.001). (B) Nonsynonymous
spleen-derived clones from clade A, D, and B viruses. The B clade
2, and YU-2 (see Fig. 1 for the source of the sequences). The second
m five patients, previously reported (Power et al., 1994, 1998). dN was
ch segment within a group was compared to the equivalent distance
indicated a difference between the groups (Tukey–Kramer, *P , 0.01gp120
depen
from DN
(the pr
t the m
of A and
in- and
L, SF16
ces fro
ce of eaand V5 hypervariable regions, whereas, within the V4
region, D clade sequences from both brain and spleen
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23HIV-1 CLADE A AND D NEUROTROPISMdisplayed significantly increased dN rates compared to
those of both B and A clade viruses. In contrast to the
above domain-specific variation dN rates, the V2, C2, C3,
and V5 regions in all viruses showed similar dN rates
Fig. 2B), indicating interclade molecular variability ex-
sted but was dependent on specific domains within
p120.
Given the extent of diversity within the present se-
uences from A and D clade viruses and a previous
eport of a high frequency of recombination events in
rain-derived viruses (Morris et al., 1999), viral recombi-
ation was examined in the present A and D clone
equences. Nucleotide sequences from all patients were
irst subjected to the scanning for recombination with the
CBI subtyping HIV-1 program and further confirmed by
ootscanning (Lole et al., 1999), the maximum x2 method,
nd bootstrap testing (Robertson et al., 1995a; Smith,
1992). NCBI subtyping detected occurrence of recombi-
nation in 37 out of 73 clones (50.7%). However, confirma-
tory methods revealed few recombination events:
bootscanning, 9 clones (12.3%); maximum x2 and boot-
trap, 1 clone (1.4%). Hence, recombination within gp120
as confirmed only in 1 of 73 clones, which was a
rain-derived clone from patient 99 (clone B99-1), using
ultiple methods. Recombination occurred between A
nd D clade viruses, spanning the V1 and V2 regions
Fig. 3A), but this recombination event was not confirmed
n other brain-derived or the matched spleen-derived
lones from the same patient, although NCBI subtyping
r the genetic similarity plot (SimPlot) (Lole et al., 1999)
howed a similar pattern (data not shown). To estimate
he location of the apparent crossover site, bootscanning
Lole et al., 1999) was performed using A and D clade
epresentative sequences and the B clade virus, HXB2,
s an out-group sequence (Fig. 3B). By the method of
aximization of x2 (Robertson et al., 1995a; Smith, 1992),
the most likely breakpoints were located in 55–233 bp
T
Comparison of Total Distance (d) and Synonymous (dS) an
and Spleen-Derived gp120 Sequenc
B-brain A-brain
d 0.0974a 6 0.0044 0.1539 6 0.0048
dS 0.1398
b 6 0.0138 0.2405 6 0.0222
dN 0.0863
c 6 0.0056 0.1317 6 0.0082
dN/dS 0.6358 6 0.0294 0.5567 6 0.0237
Note.The d value was calculated from the J-C distance using the ME
method of Nei and Gojobori (1986). See Fig. 1 for the source of B-brain s
Graphpad).
a All P , 0.001 when comparing d of B-brain with those of A-brain,
b All P , 0.01 when comparing dS of B-brain with those of A-brain a
c P , 0.001, , 0.05, , 0.01, and , 0.001 when comparing dN of B-b
d P , 0.01, , 0.001 when comparing dN/dS of D-brain with those of(Fig. 3C). This recombination event was further con-
firmed by bootstrap testing by constructing separate phy-logenetic trees of the resulting regions (with bootstrap
support of $95%) when the B99-1 clone was compared
to representative A and D clade viruses (Fig. 3D), indi-
cating that recombination occurred infrequently in this
group of patients.
Analyses of amino acid sequence alignments revealed
that the V1 region was highly divergent, as predicted
from Fig. 2B, and displayed few conserved amino acids,
but frequent deletions or insertions were observed (data
not shown). In the V3 (Fig. 4A) region, many residues
were conserved either in all clades or within individual
clade. There was a restricted position for amino acid
insertion in both regions (positions 185–191 and 317–323
in HXB2 gp120 aa numbering) for the V2 and V3 regions,
respectively. At several positions (302, 304, 306, and 309
in HXB2 gp120 aa numbering) within in the V3 region
(Fig. 4A), specific aas were highly conserved across all
brain-derived viruses and were not consistently ob-
served in the spleen-derived sequences. Like the V1 and
V2 regions, V4 and V5 (data not shown) did not show any
mutations that were clearly unique to brain-derived vi-
ruses. In addition, the present sequences revealed no
differences in amino acid composition in terms of basic
amino acid substitutions or in potential N-linked glyco-
sylation sites, which have been reported to play a direct
role in coreceptor specificity (Chesebro et al., 1996;
Milich et al., 1997) and syncytia induction capacity (Groe-
nink et al., 1993; Overbaugh and Rudensey, 1992), re-
spectively. To determine if previously reported mutations
associated with macrophage tropism or CCR5 utilization
were present in our brain-derived clones, we compared
the present sequences to previous reports (Wang et al.,
1999). Few residues associated with CCR5 utilization
were observed in the present A and D clade viruses (Fig.
4A), suggesting that these mutations may not be required
for macrophage tropism of A and D clade viruses.
The V3 hypervariable region of the gp120 env protein
ynonymous (dN) Substitution Rates (6SEM) among Brain-
m HIV-1 A, D, and B Clade Groups
D-brain A-spleen D-spleen
506 6 0.0070 0.1429 6 0.0069 0.1726 6 0.0088
656 6 0.0258 0.2025 6 0.0204 0.2239 6 0.0239
217 6 0.0087 0.1271 6 0.0081 0.1592 6 0.0105
610d 6 0.0190 0.6458 6 0.0364 0.7322 6 0.0734
gram (Kumar et al., 1993), and dS and dN were estimated based on the
es. The statistics are by Tukey–Kramer multiple comparison (INSTAT2,
, A-spleen, and D-spleen.
rain.
th those of A-brain, D-brain, A-spleen, and D-spleen, respectively.
, A-spleen, and D-spleen, respectively.ABLE 2
d Nons
es fro
0.1
0.2
0.1
0.4
GA pro
equenc
D-brain
nd D-bexpresses the principal determinants of cell tropism
(Chesebro et al., 1992, 1996; Hwang et al., 1991 West-
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24 ZHANG ET AL.FIG. 3. Analysis of recombination within the brain-derived gp120 sequence from patient 99. (A) HIV-1 subtyping plot (NCBI) using predefined HIV-1
clade consensus sequences from the RIP program as reference clade sequences, as indicated in different colors and marked at the right side. The
top part of the panel shows the color code for the reference sequence with the highest score. If there were two identical scores for a specific window
with different subtypes, the window bar divided diagonally. (B) Bootscanning plot (Lole et al., 1999) using A and D clade representative sequences
and B clade virus HXB2 as an outgroup sequence. The scanning was performed with 100 bootstrap resamplings using a neighbor-joining method
with Kimura two-parameter distance and the transition/transversion ratio of 1.3 from PHYLIP (Phylogeny Inference Package) version 3.5c (Felsenstein,
1995). The gaps were stripped and window size was set at 180 bp with a step of 20 bp. The position was marked with the corresponding segments
of gp120 and the numbering indicated below. (C) The maximum x2: Informative sites were obtained from B and the maximum x2 was calculated as
escribed (Robertson et al., 1995a; Smith, 1992). (D) The bootstrap test was done with a neighbor-joining method with pairwise gap stripping and the
-C distance, using A, D, and B representative sequences as indicated in (B). The bootstrap values were indicated at node and the distance scale
s shown for each individual tree.
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25HIV-1 CLADE A AND D NEUROTROPISMervelt et al., 1992) and coreceptor use (Chan et al., 1999;
hoe et al., 1996; Cocchi et al., 1996; Speck et al., 1997).
Transfer of a V3 loop from one virus into a distinct HIV-1
background typically retains the coreceptor usage profile
of the V3 donor virus (Chan et al., 1999; Choe et al., 1996;
Speck et al., 1997). To explore the tropism of the current
non-B clade viruses, we constructed chimeric viruses
containing the C2V3 region (corresponding to 6825–7268
FIG. 4. Comparison of representative predicted amino acid sequenc
rain- and spleen-derived clones and utilization of CCR5 (B), CXCR4 (C
ach patient was included. Brain-derived B clade consensus sequence
t the top with HXB2 amino acid numbering. Consensus sequences for
atabase and indicated at the top for each group. The residues previou
re circled. The shaded amino acids were highly conserved across a
equences. A solid box indicates the tetrametric tip of the V3 loop m
lasmids NL-B118 and NL-JRFL contain chimeric pNL4-3 provirus with
rain-derived gp120 sequence of patient 118 (B118-1) or the JRFL gp12
reviously described luciferase reporter virus infection assay (Chan e
ifferent chemokine receptors were HeLa-CD4/CXCR4/CCR5 (B), HeLa
CR3 (D). The results represent the geometric means (marked on
xperiment), showing marked infection by the chimeric viruses of the H
host-CD4/CXCR4/CCR3 (D). pNL4-3 infected all cell lines, indicative
ucE2R2.bp) derived from all patients’ brain- and spleen-derived
sequences, as well as from JRFL (as a positive control),in the genomic backbone of pNL4-3, which is T-tropic
and preferentially uses CXCR4 chemokine receptor. A
live chimeric virus was obtained, which replicated at
similar levels to the parent virus in peripheral blood
mononuclear cells (PBMCs) (data not shown). This chi-
meric virus contained an A clade brain-derived sequence
(clone B118-1) from patient 118. To determine chemokine
receptor utilization by this virus, a pseudotype luciferase
3 (A) regions of gp120 among HIV-1 clade B brain- and A and D clade
CCR3 (D) as coreceptors. A representative clone for each tissue from
obtained from previous reports (Power et al., 1994, 1998) and indicated
nd D clade viruses were obtained from the Los Alamos HIV Sequence
sociated with CCR5 chemokine receptor utilization in the B clade virus
-derived viruses but not consistently observed in the spleen-derived
d dot boxes indicate the restricted position for amino acid insertion.
bp insertion (StuI–NheI) that included the C2V3 region of the clade A
ence, respectively. Chemokine receptor utilization was assayed by a
999). Viral supernatants used to infect different cell lines expressing
XCR4 (Clone 1022) (C), and human osteosarcoma Ghost-CD4/CXCR4/
each bar) of the data from two experiments (triplicate wells/each
D4/CXCR4/CCR5 cells (B), but no infection of HeLa-CD4/CXCR4 (C) or
ogenous CXCR4 expression. Mock represents infection with pNL4-3-es of V
), and
s were
B, A, a
sly as
ll brain
otif an
a 443-
0 sequ
t al., 1
-CD4/C
top for
eLa-Creporter virus infection assay was carried out as previ-
ously described (Chan et al., 1999). The A clade brain-
i
(
i
b
i
i
q
c
a
d
p
a
c
a
d
c
c
T
t
r
d
M
S
(
i
y
b
(
p
o
s
f
m
s
m
g
d
i
n
i
c
e
m
g
g
(
e
A
v
d
g
1
c
c
o
p
26 ZHANG ET AL.derived chimeric virus (NL-B118) preferentially used
CCR5 as a coreceptor (Fig. 4B), but did not infect CXCR4-
(Fig. 4C) or CCR3- (Fig. 4D) expressing cells, similar to
the prototype brain-derived B clade virus, JRFL. Chimeric
viruses containing brain-derived sequences from three
other patients (D clade, B75-1, and A clade, B99-1 and
B104-5) were passaged repeatedly but replicated at low
levels in PBMCs. These latter viruses also exhibited a
preference for CCR5 as a coreceptor by infection of HeLa
CD4/CXCR4/CCR5 or HeLa CD4/CXCR4 detected by p24
immunostaining (data not shown), indicating that infec-
tion of non-B clade viruses shared a similar cell tropism
and chemokine coreceptor utilization in the brain to
those of B clade HIV-1 strains.
DISCUSSION
The present studies represent several important find-
ings, including: (1) marked differences in evolutionary
parameters between sequences from different clades,
which depended on the specific domains within env and
the tissue from which the sequences were derived; (2)
infrequent occurrence of viral recombination despite us-
ing rigorous methodologies and the increased potential
of recombination because of the presence of multiple
clades in this geographic region; and (3) evidence for
CCR5 utilization by a brain-derived non-B clade recom-
binant virus. Earlier reports of B clade brain-derived
HIV-1 env sequences revealed limited molecular variabil-
ty compared to viral sequences from blood and spleen
Li et al., 1991; Pang et al., 1991; Power et al., 1994). Of
nterest, V1-V3 sequences for both groups of B clade
rain-derived clones demonstrated no major differences
n molecular diversity despite different methods of virus
solation. Among the present brain-derived env se-
uences, A and D clade viruses were highly divergent,
ompared to B clade brain-derived viral sequences. In
ddition, D clade viruses showed greater evolutionary
istances than the corresponding A clade sequences. A
otential explanation for the increased diversity may be
difference in host-specific modulation of the selective
onstraints that drive viral gene evolution (Bagnarelli et
l., 1999), although the present patients were all AIDS-
efined and from the same center. Since multiple HIV-1
lades are present in Nairobi, viral genetic diversity
ould also arise through recombination events (Hu and
emin, 1990; Katz and Skalka, 1990). Proviral genomes
hat are mosaic over the length of the genome as well as
ecombinant forms of individual HIV-1 genes have been
escribed (Carr et al., 1996; Cornelissen et al., 1996; Gao
et al., 1996a,b; Leitner et al., 1995; Lole et al., 1999;
cCutchan et al., 1996b; Robertson et al., 1995a,b);
alminen et al., 1997; Takehisa et al., 1999). Neilson et al.
1999) detected 2.2% interclade recombinant env genes
n Nairobi, Kenya, but they predicted that .20% of Ken-
an HIV-1 proviral genomes would be interclade recom-inants. However, the present studies detected one
1.4%) A and D interclade gp120 sequence among nine
atients using multiple confirmatory methods. Detection
f interclade recombinants only in brain implies that at
ome earlier time point the brain may have been coin-
ected with A and D clade viruses and recombination
ay have occurred within the brain. This supposition is
upported by Morris et al. (1999), who observed the
osaic structure of p17gag, pol, hypervariable regions of
p120, and gp41/nef being assembled within brain from
ifferent combinations of evolutionarily distinct lineages
n B clade virus. However, the possibility that recombi-
ation may have occurred outside brain prior to neuro-
nvasion must also be considered. Nonetheless, in-
reased molecular diversity within brain-derived HIV-1
nv sequences has been associated with the develop-
ent of HIV dementia (Power et al., 1994). In addition,
reater viral molecular diversity has also been sug-
ested as a determinant of systemic HIV-1 virulence
Markham et al., 1998; Wolinsky et al., 1996), which may
xplain in part shorter survival times in sub-Saharan
frica, especially in persons infected with HIV-1 D clade
iruses (Kanki et al., 1999).
Selective pressures within the microenvironments of
ifferent anatomic compartments result in the emer-
ence of dominant HIV-1 quasispecies (Bagnarelli et al.,
999; Wong et al., 1997). The present study of A and D
lade viruses showed that brain- and spleen-derived
lones from the same patient differed significantly. More-
ver, both A and D clade brain-derived sequences dis-
layed lower dN/dS ratios compared to those of the cor-
responding spleen-derived viruses. These latter findings
suggest that the effects of selective pressure may be
less on brain-derived A or D clade viruses than on
spleen-derived viruses (Bagnarelli et al., 1999), perhaps
due to the brain being a relatively immunologically iso-
lated compartment (Streilein and Taylor, 1997). The ex-
tent of sequence divergence between brain- and spleen-
derived sequences differed depending on the domain
within gp120 and the individual viral clade. For example,
within the V4 and V3 regions, there was greater diversity
between brain and spleen among D clade viruses than
among A clade viruses, while the converse was true for
the V1 region, where the diversity within the A clade
sequences were greater than within the D clade. This
result underscores Ping et al.’s finding (1999), which
indicated that the V3 region of the X4-like B clade se-
quences was significantly more variable than the V3
region of the B clade R5-like sequences (with similar
variability in other regions for both groups), whereas the
subtype C sequences in the V4 region exhibited signifi-
cantly greater variability than comparable sequences
from clade B viruses. Together, these data suggest that
discrete domains can be affected by selective pressures
depending on the viral clade and coreceptor preference.
Brain or spleen tissue-specific signature sequences in
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27HIV-1 CLADE A AND D NEUROTROPISMthe present A and D clade viruses could not be identified,
despite previous reports of brain-specific sequences
(Korber et al., 1994). The survival of patients infected with
HIV-1 B clade virus in North America and Europe is
estimated to be 10–15 years (O’Brien et al., 1996),
hereas survival time and the time to AIDS development
n Africa is shorter (Del Amo et al., 1998; Kanki et al.,
999; Robinson and Marindo, 1999; Spira et al., 1999;
imaeus, 1998); thus, perhaps not enough time had
lapsed for A and D clade viruses to evolve tissue-
pecific signature sequences, as suggested by other
revious studies (Gartner et al., 1997; Nowak et al., 1991;
olinsky et al., 1996).
A single chimeric virus was obtained from the present
on-B clade sequences that replicated at high levels in
BMCs. However, utilization of CCR5 as a coreceptor by
his A clade brain-derived chimeric virus suggests that
nfection of A clade viruses may share similar cell tro-
ism and chemokine coreceptor utilization in the brain to
hose of B clade HIV-1 strains (Chan et al., 1999; Power
t al., 1998). Nonetheless, brain-derived chimeric viruses
rom three other patients replicated at low levels, possi-
ly due to incompatability between non-B clade se-
uences with NL4-3, despite exhibiting a preference for
CR5 as a coreceptor. The low levels of infection by
hese latter recombinant viruses may also reflect prop-
rties of brain-derived viruses, which tend to replicate at
ower levels that the parent T cell tropic viruses or M-
ropic viruses derived from organs other than brain
Chesebro et al., 1992; Ohagen et al., 1999; Power et al.,
995).
MATERIALS AND METHODS
ubject and frozen tissues
Frozen brain and spleen were obtained at autopsy
ith consent as part of a prospective study of HIV-1
eropositive adult patients with AIDS admitted to Ken-
atta National Hospital in Nairobi, Kenya (Rana et al.,
000). Nine patients were included in this study and their
eneral autopsy findings and clinical features are sum-
arized in Table 1.
ested PCR, molecular cloning, and sequencing
The complete env gene was amplified directly from
enomic DNA and extracted with DNAzol (GIBCO BRL)
rom matched brain and spleen samples in nine patients,
sing a nested PCR protocol (outer primers, 59-AGA GCA
AA GAC AGT GGC AAT-39 and 59-TTT TGA CCA CTT
CC ACC CAT-39; inner primers, 59-ATG AGA GTG AAG
GG ATA CAG AGG AAT-39 and 59-TTA TAG GAA AGC
CT TTC TAA GCC CTG-39, corresponding to HXB2 nu-
leotide position numbers 6206–6226, 8817–8797, 6225–
252, and 8795–8769, respectively) using Taq polymer-
se and AmpliWax PCR Gem 50 (Perkin–Elmer) accord-
r
ong to the manufacturer’s instructions. PCR products
ere purified using Gel Extraction Kit 150 (Qiagen) and
hen ligated into pcDNA3.1 using Eukaryotic TOPO TA
loning kit (Invitrogen). DNA sequencing was performed
n both directions with internal primers spanning the
1-V5 regions of gp120, using ABI PRISM Big Dye Ter-
inator Cycle Sequencing and ABI 373A automated se-
uencer (Applied Biosystems). Regions corresponding to
he PCR amplification primers were excluded from the
equence analysis.
equence analyses
HIV-1 clade typing was performed with the NCBI Sub-
yping HIV-1 program (URL: http://www.ncbi.nlm.nih.gov)
the representative sequences were updated September,
000). The DNAStar software package (DNAStar Inc.)
as used to align the sequences and determine the
imilarity and divergence among the sequences. Estima-
ions of total distance and synonymous and nonsynony-
ous distances were based on the method of Nei and
ojobori (1986). Phylogenetic and bootstrap analyses
ere carried out with the MEGA program (Kumar et al.,
993). For analysis of evolutionary distance for the enve-
ope segments, envelope sequences spanning V1
hrough V5 were aligned using Clustal method from
NAStar. The alignments were optimized manually to
nsure that codons remained intact and gaps were min-
mized. Sequences were then divided into segments of
round 25–50 codons, based on the location of hyper-
ariable and conserved domains.
ecombination analyses
The sequences were first subjected to scanning for
ecombination with the NCBI subtyping HIV-1 program
sing the representative sequences from the program (to
e updated September 2000) and the predefined HIV-1
ubtype consensus sequences from the RIP program on
he world wide web at URL http://hiv-web.lanl.gov (up-
ated November 1999). The distance plot and bootscan-
ing were performed using the SimPlot program (Lole et
l., 1999) to identify informative sites and a cluster anal-
sis maximizing the value of x2 (maximum x2 test) was
hen used to select crossover breakpoints (Robertson et
l., 1995a; Smith, 1992). These breakpoints were used to
ivide the alignment into segments for phylogenetic tree
onstruction and the recombination event was further
onfirmed by bootstrap testing as described above.
onstruction of chimeric proviruses and coreceptor
tilization assay for single-round infection
Molecular clones pNL4-3 and pNL-Luc-E2R2 (the
L4-3 provirus backbone with a luciferase reporter gene
nsertion) and cell lines expressing different chemokine
eceptors, HeLa-CD4/CXCR4 (Clone 1022), and human
steosarcoma Ghost-CD4/CXCR4/CCR3, were obtained
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28 ZHANG ET AL.from the AIDS Research and Reference Reagent Pro-
gram, Division of AIDS, National Institute of Allergy and
Infectious Diseases. Plasmids NL-B118 and NL-JRFL
containing chimeric NL4-3 provirus with a 443-bp inser-
tion (StuI-NheI) that included the C2V3 region (corre-
sponding to 6825–7268 bp in HXB2 numbering) of clade
A of the brain-derived gp120 sequence of patient 118
(B118-1) or the JRFL gp120 sequence, respectively, were
constructed as reported (Power et al., 1998). Chemokine
eceptor utilization was assayed by a previously de-
cribed luciferase reporter virus infection assay (Chan et
al., 1999). Briefly, chimeric virus and pNL-Luc-E2R2 plas-
ids were transfected into 293T cells using CaPO4. Viral
upernatants were harvested 2 days posttransfection,
leared of cell debris by low-speed centrifugation, and
sed to infect different cell lines expressing different
hemokine receptors. Infection of target cells by
seudotyped virus led to expression of luciferase, which
as quantified in cell lysates 2 days following addition of
irus, using the Luciferase Assay Kit (PharMingen, Can-
da).
tatistical analysis
Statistical analyses were performed using Instat,
raphpad, for both parametric and nonparametric com-
arisons. P values of less than 0.05 were considered
ignificant.
ucleotide sequence Accession Numbers
The present nucleotide sequences have been submit-
ed to GenBank.
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